Skip to main content
. 2023 Nov 4;9(11):e21846. doi: 10.1016/j.heliyon.2023.e21846

Table 2.

Effects of KRGF on body weight, food intake, food efficacy ratio and liver weight in NAFLD-induced rats (mean ± SD, n = 8).

NC HF LD HD PC
Initial BW (g) 346.75 ± 15.83 353.63 ± 23.48 352.63 ± 31.40 361.75 ± 28.06 366.25 ± 17.30
Final BW (g) 407.38 ± 27.32 442.50 ± 23.32# 436.88 ± 36.20 445.25 ± 40.57 433.38 ± 19.05
BW gains (g) 60.63 ± 27.26 88.88 ± 8.32## 84.25 ± 9.43 83.50 ± 17.67 67.13 ± 16.13*
Food intake (g) 588.71 ± 13.96 688.97 ± 5.76### 669.52 ± 22.32* 702.76 ± 7.47 669.54 ± 13.16*
FER (%) 10.25 ± 4.60 12.90 ± 1.19 12.57 ± 1.15 11.89 ± 2.55 10.00 ± 2.29*
Liver weight (g) 11.06 ± 0.87 18.25 ± 1.33### 18.45 ± 1.18 18.65 ± 1.83 18.95 ± 1.48
Liver weight/BW (%) 2.70 ± 0.16 4.06 ± 0.19### 4.10 ± 0.34 4.13 ± 0.22 4.38 ± 0.35

BW, body weight; FER, food efficacy ratio = (body weight gain/food intake) × 100 %; NC, normal control group; HF, HFD-induced control group; LD, HFD + low-dose KRGF (325 mg/kg/day); HD, HFD + high-dose KRGF (650 mg/kg/day); PC, HFD + fenofibrate (25 mg/kg/day). Values are expressed as mean ± SD (n = 8 for each group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs. NC; *p < 0.05 vs. HF.